Idexx Laboratories | IDXX - Nettoeinkommen

Aktienkurs
580.76
Täglich Wechseln
-3.29 -0.56%
Monatlich
-0.96%
Jährlich
44.33%
Q2 Prognose
547.63




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
Accuray USD 2.54M 6.49M 2024-12
Align Technology USD 135.76M 79.01M 2025-12
AngioDynamics USD -6.35M 4.55M 2025-09
Dentsply International USD -146M 281M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Fujifilm JPY 72.66B 6.27B 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Henry Schein USD 101M 0 2025-12
Idexx Laboratories USD 248.19M 26.42M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
Masimo USD 68.3M 168.7M 2025-12
Neogen USD -17M 1.08M 2025-12
Orthofix International USD -2.22M 20.57M 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
ResMed USD 392.59M 44.06M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Steris USD 192.9M 1000K 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Zoetis USD 603M 118M 2025-12